Effect of IL-1β, PGE2, and TGF-β1 on the expression of OPG and RANKL in normal and osteoporotic primary human osteoblasts

Journal of Cellular Biochemistry

Volumn 110, Issue 2, 2010, Pages 304-310

  Jurado, Susana ^a   Garcia Giralt, Natalia ^a   Díez Pérez, Adolfo ^a   Esbrit, Pedro ^b   Yoskovitz, Guy ^a   Agueda, Lídia ^c,d   Urreizti, Roser ^c,d   Pérez Edo, Lluís ^a   Saló, Guillem ^a   Mellibovsky, Leonardo ^a   Balcells, Susana ^c,d   Grinberg, Daniel ^c,d   Nogués, Xavier ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b Hospital UniversitarioFundación Jiménez Díaz   (Spain)

^c UNIVERSITY OF BARCELONA   (Spain)

^d CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE ENFERMEDADES RARAS CIBERER   (Spain)

Author keywords

Cytokines; Expression; OPG; Osteoblasts; Protein; RANKL

Indexed keywords

INTERLEUKIN 1BETA; MESSENGER RNA; OSTEOCLAST DIFFERENTIATION FACTOR; PROSTAGLANDIN E2; TRANSFORMING GROWTH FACTOR BETA1; OSTEOPROTEGERIN; TNFSF11 PROTEIN, HUMAN;

ARTICLE; CELL CULTURE; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; OSTEOBLAST; OSTEOLYSIS; PRIMARY OSTEOPOROSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TREATMENT RESPONSE; CASE CONTROL STUDY; CYTOLOGY; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; OSTEOPOROSIS; POLYMERASE CHAIN REACTION;

CASE-CONTROL STUDIES; CELLS, CULTURED; DINOPROSTONE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION REGULATION; HUMANS; INTERLEUKIN-1BETA; OSTEOBLASTS; OSTEOPOROSIS; OSTEOPROTEGERIN; POLYMERASE CHAIN REACTION; RANK LIGAND; TRANSFORMING GROWTH FACTOR BETA1;

EID: 77952070589     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.22538     Document Type: Article

References (25)

1. Anderson DM, Maraskovsky E, Billingsley WL, Dougall WC, Tometsko ME, Roux ER, Teepe MC, DuBose RF, Cosman D, Galibert L. 1997. A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function. Nature 390:175-179. (Pubitemid 27507987)
2. Balla B, Kosa JP, Kiss J, Borsy A, Podani J, Takacs I, Lazary A, Nagy Z, Bacsi K, Speer G, Orosz L, Lakatos P. 2008. Different gene expression patterns in the bone tissue of aging postmenopausal osteoporotic and non-osteoporotic women. Calcif Tissue Int 82:12-26.
3. Brandstrom H, Jonsson KB, Ohlsson C, Vidal O, Ljunghall S, Ljunggren O. 1998. Regulation of osteoprotegerin mRNA levels by prostaglandin E2 in human bone marrow stroma cells. Biochem Biophys Res Commun 247:338-341. (Pubitemid 28420824)
4. Centrella M, Horowitz MC, Wozney JM, McCarthy TL. 1994. Transforming growth factor-beta gene family members and bone. Endocr Rev 15:27-39. (Pubitemid 2059040)
5. Darnay BG, Haridas V, Ni J, Moore PA, Aggarwal BB. 1998. Characterization of the intracellular domain of receptor activator of NF-kappaB (RANK). Interaction with tumor necrosis factor receptor-associated factors and activation of NF-kappab and c-Jun N-terminal kinase. J Biol Chem 273:20551-20555. (Pubitemid 28377625)
6. Dinarello CA. 1988. Biology of interleukin 1. FASEB J 2:108-115.
7. Fuller K, Lean JM, Bayley KE, Wani MR, Chambers TJ. 2000. A role for TGFbeta(1) in osteoclast differentiation and survival. J Cell Sci 113(Pt 13): 2445-2453.
8. Garcia-Moreno C, Mendez-Davila C, de La Piedra C, Castro-Errecaborde NA, Traba ML. 2002. Human prostatic carcinoma cells produce an increase in the synthesis of interleukin-6 by human osteoblasts. Prostate 50:241-246. (Pubitemid 34184663)
9. Hofbauer LC, Heufelder AE. 2001. Role of receptor activator of nuclear factor-kappaB ligand and osteoprotegerin in bone cell biology. J Mol Med 79:243-253.
10. Hofbauer LC, Dunstan CR, Spelsberg TC, Riggs BL, Khosla S. 1998. Osteoprotegerin production by human osteoblast lineage cells is stimulated by vitamin D, bone morphogenetic protein-2, and cytokines. Biochem Biophys Res Commun 250:776-781. (Pubitemid 28484803)
11. Hofbauer LC, Lacey DL, Dunstan CR, Spelsberg TC, Riggs BL, Khosla S. 1999. Interleukin-1beta and tumor necrosis factor-alpha, but not interleukin-6, stimulate osteoprotegerin ligand gene expression in human osteoblastic cells. Bone 25:255-259. (Pubitemid 29406050)
12. Kolar P, Lach S, Gaber T, Maschmeyer P, Dziurla R, Tripmacher R, Krocker D, Matziolis G, Perka C, Burmester GR, Buttgereit F. 2009. Effects of celecoxib on the expression of osteoprotegerin, energy metabolism and cell viability in cultured human osteoblastic cells. Clin Exp Rheumatol 27:99-107.
13. Lacey DL, Timms E, Tan HL, Kelley MJ, Dunstan CR, Burgess T, Elliott R, Colombero A, Elliott G, Scully S, Hsu H, Sullivan J, Hawkins N, Davy E, Capparelli C, Eli A, Qian YX, Kaufman S, Sarosi I, Shalhoub V, Senaldi G, Guo J, Delaney J, Boyle WJ. 1998. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93:165-176. (Pubitemid 28180851)
14. Li X, Pilbeam CC, Pan L, Breyer RM, Raisz LG. 2002. Effects of prostaglandin E2 on gene expression in primary osteoblastic cells from prostaglandin receptor knockout mice. Bone 30:567-573. (Pubitemid 34270493)
15. Liu XH, Kirschenbaum A, Yao S, Levine AC. 2006. Interactive effect of interleukin-6 and prostaglandin E2 on osteoclastogenesis via the OPG/RANKL/RANK system. Ann N Y Acad Sci 1068:225-233. (Pubitemid 43824153)
16. Murakami T, Yamamoto M, Ono K, Nishikawa M, Nagata N, Motoyoshi K, Akatsu T. 1998. Transforming growth factor-beta1 increases mRNA levels of osteoclastogenesis inhibitory factor in osteoblastic/stromal cells and inhibits the survival of murine osteoclast-like cells. Biochem Biophys Res Commun 252:747-752. (Pubitemid 28556848)
17. Raisz LG. 1999. Prostaglandins and bone: Physiology and pathophysiology. Osteoarthritis Cartilage 7:419-421.
18. Sakata M, Shiba H, Komatsuzawa H, Fujita T, Uchida Y, Yoshino H, Ogawa T, Kawaguchi H, Kurihara H. 2002. Osteoprotegerin levels increased by interleukin-1beta in human periodontal ligament cells are suppressed through prostaglandin E(2) synthesized de novo. Cytokine 18:133-139. (Pubitemid 34775434)
19. Simonet WS, Lacey DL, Dunstan CR, Kelley M, Chang MS, Luthy R, Nguyen HQ, Wooden S, Bennett L, Boone T, Shimamoto G, DeRose M, Elliott R, Colombero A, Tan HL, Trail G, Sullivan J, Davy E, Bucay N, Renshaw-Gegg L, Hughes TM, Hill D, Pattison W, Campbell P, Sander S, Van G, Tarpley J, Derby P, Lee R, Boyle WJ. 1997. Osteoprotegerin: A novel secreted protein involved in the regulation of bone density. Cell 89:309-319. (Pubitemid 27199902)
20. Takai H, Kanematsu M, Yano K, Tsuda E, Higashio K, Ikeda K, Watanabe K, Yamada Y. 1998. Transforming growth factor-beta stimulates the production of osteoprotegerin/osteoclastogenesis inhibitory factor by bone marrow stromal cells. J Biol Chem 273:27091-27096. (Pubitemid 28500414)
21. Torricelli P, Fini M, Giavaresi G, Giardino R. 2003. Osteoblasts cultured from osteoporotic bone: A comparative investigation on human and animal-derived cells. Artif Cells Blood Substit Immobil Biotechnol 31:263-277. (Pubitemid 36917866)
22. Vega D, Maalouf NM, Sakhaee K. 2007. Clinical Review #: The role of receptor activator of nuclear factor-kappaB (RANK)/RANK ligand/osteoprotegerin: Clinical implications. J Clin Endocrinol Metab 92:4514-4521. (Pubitemid 350223419)
23. Velasco J, Zarrabeitia MT, Prieto JR, Perez-Castrillon JL, Perez-Aguilar MD, Perez-Nunez MI, Sanudo C, Hernandez-Elena J, Calvo I, Ortiz F, Gonzalez-Macias J, Riancho JA. 2009. Wnt pathway genes in osteoporosis and osteoarthritis: Differential expression and genetic association study. Osteoporos Int 21:109-118.
24. Wong BR, Josien R, Lee SY, Sauter B, Li HL, Steinman RM, Choi Y. 1997. TRANCE (tumor necrosis factor [TNF]-related activation-induced cytokine), a new TNF family member predominantly expressed in T cells, is a dendritic cell-specific survival factor. J Exp Med 186:2075-2080. (Pubitemid 28013694)
25. Yasuda H, Shima N, Nakagawa N, Yamaguchi K, Kinosaki M, Mochizuki S, Tomoyasu A, Yano K, Goto M, Murakami A, Tsuda E, Morinaga T, Higashio K, Udagawa N, Takahashi N, Suda T. 1998. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc Natl Acad Sci USA 95:3597-3602. (Pubitemid 28173173)